Phase 4 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Obstructive Sleep Apnea (a condition where breathing repeatedly stops during sleep) confirmed by an overnight sleep study
- People whose blood pressure does not drop as expected during sleep, as measured by a device worn to monitor blood pressure over 24 hours
Who may not be able to join:
- People who are currently taking medication for sleep problems or psychiatric (mental health) conditions
- People who currently use a CPAP or BiPAP machine (a breathing device worn during sleep to keep the airway open)
- People who have a neurological (brain or nervous system) or psychiatric (mental health) condition
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Matilde Valencia-Flores, PhD, National Institute of Medical Sciences and Nutrition Salvador Zubirán (INCMNSZ)
Phone: (+52 55) 54870900
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Melatonin at a dose of 3 mg before sleep time, after a period of 30 days changes the time awake after sleep onset (WASO), and recovers the dipper pattern of blood pressure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.